IntelliCyt Corp collects $7.4 mln
Albuquerque, New Mexico-based IntelliCyt Corp, a provider of integrated platforms to accelerate drug discovery, antibody discovery and immunology, has closed $7.4 million in new financing, which includes $5.4 million in venture financing and a $2 million debt facility. Arboretum Ventures led the venture funding round with participation from current backers Prolog Ventures, Verge Fund and New Mexico Community Capital. Oxford Finance provided the debt funding.
22 October 2015•3 mins read
